Project Overview

The ThrombUS+ project is focused on developing a novel wearable diagnostic device to aid in the early detection and diagnosis of deep vein thrombosis (DVT). The project integrates cutting-edge technologies, including ultrasound, artificial intelligence, light reflection rheography, plethysmography, serious games, and extended reality, to create a comprehensive and user-friendly monitoring system. ThrombUS+ aims to provide patients and healthcare professionals with real-time insights, enhancing DVT diagnosis and treatment.

The ThrombUS+ project is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 101137227 (Horizon Innovation Action | HORIZON-HLTH-2023-TOOL-05-05) and is co-funded by the European Union.

42 months
Starting Date: 1 January 2024

Ending Date: 30 June 2027

18 partners from Greece, Lithuania, France, Germany, USA, Italy, Finland and Spain

9.5 M€ budget
co-funded by the Horizon Europe Programme

Wearable Continuous Point-of-Care Monitoring, Risk Estimation and Prevention for Deep Vein Thrombosis

News & Events

Meet the Partner: TELEMED

Telemed is a pioneer in the field of medical imaging and ultrasound technology. Read about their involvement in the ThrombUS+ […]

Meet the Partner: Fraunhofer IPMS

Fraunhofer IPMS is a pivotal member of the ThrombUS+ project. Read more about their involvement in developing a novel wearable […]

ThrombUS+ Presented at EMBEC 2024

The ThrombUS+ Horizon Europe project was presented at the 9th European Medical and Biological Engineering Conference (EMBEC) in June 2024 […]

Subscribe to ThrombUS+

* indicates required

Horizon Innovation Action | Agreement No. 101137227
HORIZON-HLTH-2023-TOOL-05-05
Co-funded by the European Union